Your browser doesn't support javascript.
loading
Coengagement of CD2 with LFA-1 or VLA-4 by bispecific ligand fusion proteins primes T cells to respond more effectively to T cell receptor-dependent signals.
Dietsch, M T; Chan, P Y; Kanner, S B; Gilliland, L K; Ledbetter, J A; Linsley, P S; Aruffo, A.
Afiliação
  • Dietsch MT; Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121.
J Leukoc Biol ; 56(4): 444-52, 1994 Oct.
Article em En | MEDLINE | ID: mdl-7523557
ABSTRACT
To examine the effects of ligand engagement and accessory molecule juxtaposition on T cell receptor (TCR) signaling, we prepared LFA-3/ICAM-1 Rg and LFA-3/VCAM-1 Rg bispecific immunoglobulin fusion proteins (Rg, recombinant globulin). These novel fusion proteins allowed us to examine the effects of ligand driven co-engagement of T cell proteins CD2 and LFA-1 or CD2 and VLA-4 on TCR-dependent mobilization of intracellular Ca2+. We observed that preincubation of resting T cells with LFA-3/ICAM-1 Rg or LFA-3/VCAM-1 Rg fusion proteins resulted in significantly enhanced mobilization of intracellular Ca2+ following TCR-accessory molecule cross-linking relative to T cells preincubated with each of the monospecific Rgs alone or with combinations of the monospecific Rg fusion proteins. In addition, such coengagement stimulated TCR-dependent activation and tyrosine phosphorylation of phospholipase C gamma 1 (PLC gamma 1). These results suggest that when T cells interact with antigen presenting cells the engagement of multiple cell adhesion molecules such as CD2, LFA-1, and VLA-4 primes the T cell to respond more effectively to signals delivered through the TCR.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Receptores de Antígeno muito Tardio / Antígeno-1 Associado à Função Linfocitária / Antígenos CD2 Limite: Humans Idioma: En Revista: J Leukoc Biol Ano de publicação: 1994 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Receptores de Antígeno muito Tardio / Antígeno-1 Associado à Função Linfocitária / Antígenos CD2 Limite: Humans Idioma: En Revista: J Leukoc Biol Ano de publicação: 1994 Tipo de documento: Article